By

Dr. Tiffany Jiang

Asia Pacific Marketing Manager, Beckman Coulter

Abstract:

As life science research has been making tremendous progresses over time, we have entered post Human Genome Project era. New clinical discovery and medicine will make more impacts on our lives, focusing on genes, their expression products and the interactions of those products in cells. Those studies will help to further understand the mechanism of diseases, enable us to develop new and effective treatments and drugs. This presentation will discuss the trend of gene expression analysis highlighting novel XP-PCR method to improve linearity and efficiency through multiplex quantitative approach. This technology is widely applied by top tumor centers (MD Anderson, MSK, NCI, etc) for prognosis prediction of Glioblastoma and prostate cancer with FFPE samples, SBRCT tumor typing, and single cell analysis. Recent publications in Nature Medicine and PNAS illustrated the importance of fast and accurate quantitative analysis for immunotherapy and cellular analysis. Scientific results in stem cell, respiratory viral and pharmaceutical analysis will be discussed as well.